Thabiso B. Seiphetlo

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

CD4+ T cell markers associated with Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic acid and Ibuprofen as Adjunctive Therapy.

CD4+ T cell markers associated with Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic acid and Ibuprofen as Adjunctive Therapy.

Journal: The Journal of infectious diseases
Published: March 04, 2026

Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.

Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.

Journal: Frontiers in immunology
Published: April 10, 2024

Bacterial microbiome and host inflammatory gene expression in foreskin tissue.

Bacterial microbiome and host inflammatory gene expression in foreskin tissue.

Journal: Heliyon
Published: June 10, 2023

A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.

A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.

Journal: AIDS (London, England)
Published: June 08, 2023

Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication.

Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication.

Journal: PloS one
Published: May 24, 2023

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen.

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen.

Journal: Trials
Published: March 22, 2023

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.

Journal: EBioMedicine
Published: February 08, 2023

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen.

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen.

Journal: Vaccines
Published: November 25, 2022

Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.

Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.

Journal: Frontiers in immunology
Published: August 02, 2022

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.

Journal: Frontiers in immunology
Published: June 09, 2022

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue.

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue.

Journal: Pharmaceutics
Published: May 03, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026